Stock Markets update: UBS launches on Xetra & HSBC uses EurexOTC clear 

New UBS equity index ETF launched on Xetra
ETF provides first-time access to Japanese companies focussed on sustainability

A new equity index ETF issued by UBS ETF Sicav has been tradable on Xetra and Börse Frankfurt since Thursday.

ETF name: UBS ETF – MSCI Japan Socially Responsible UCITS ETF
Asset class: equity index ETF
ISIN: LU1230561679
Total expense ratio: 0.4 percent
Distribution policy: distributing
Benchmark: MSCI Japan Socially Responsible Index

The UBS ETF – MSCI Japan Socially Responsible UCITS ETF enables investors to participate for the first time in the performance of Japanese companies from the MSCI Japan Socially Responsible Index. The index includes only those companies that exhibit particularly high ETS ratings in the environmental, social and governance categories. It excludes companies whose products have negative social or environmental impacts.

The product offering in Deutsche Börse’s XTF segment currently comprises a total of 1,087 exchange traded funds. This selection, together with an average monthly trading volume of over €16 billion, makes Xetra Europe’s leading trading venue for ETFs.

Source: Deutsche Börse AG.

---

 

HSBC France new user of EurexOTC Clear

Eurex Clearing, Europe’s leading clearing house and part of Deutsche Börse  Group, announced that HSBC France is a new user of EurexOTC Clear for Interest  Rate Swaps (IRS). The company has been connected as direct clearing member and  has already cleared first transactions via EurexOTC Clear. The Paris-based HSBC  France is a subsidiary of one of the largest banks worldwide.

“EurexOTC Clear will enable HSBC France to expand the support to its clients’  needs for OTC clearing. They will benefit from significant operational and  capital efficiencies as well as collateral management services,” said Xavier Boisseau, Deputy Head of Global Banking and Markets, HSBC France.

“We are delighted that HSBC France has decided to also use our OTC clearing service for its interest rate swaps business. Our offering helps to ease the rising costs of regulation by benefitting from margin, capital and collateral efficiency,” said Matthias Graulich, Chief Client Officer, Eurex Clearing.

Currently, around 50 clearing members and more than 80 buy-side firms are connected to Eurex Clearing’s OTC service. The transaction volume and open interest continue to grow despite the delay of the clearing obligation in Europe.

EurexOTC Clear is designed for clients who are focused on safety and efficiency for their OTC derivatives exposure. At the same time, the service delivers capital efficiencies to promote cost-efficient compliance with regulatory requirements based on a variety of factors including a cross-product service portfolio, a broad eligible collateral spectrum and the Eurex Clearing Prisma risk management system across listed and OTC derivatives.

Eurex Clearing offers fully integrated execution with clearing and collateral management of OTC and listed derivatives in a single clearing house within one single legal and operational framework.

Source: eurexgroup

---